Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses.

Nobukawa B, Fujii H, Hirai S, Kumasaka T, Shimizu H, Matsumoto T, Suda K, Futagawa S.

Am J Surg Pathol. 1999 Oct;23(10):1280-7.

PMID:
10524531
2.

Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.

Arakawa A, Fujii H, Matsumoto T, Hirai S, Suda K.

Hum Pathol. 2004 Apr;35(4):418-23.

PMID:
15116321
3.

Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E.

Cancer Res. 1996 Nov 15;56(22):5260-5.

4.

Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.

Hoang MP, Callender DL, Sola Gallego JJ, Huang Z, Sneige N, Luna MA, Batsakis JG, El-Naggar AK.

Int J Oncol. 2001 Oct;19(4):865-71.

PMID:
11562768
5.

Genetic classification of combined hepatocellular-cholangiocarcinoma.

Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, Fukusato T, Uekusa T, Takagaki T, Kadowaki N, Shirai T.

Hum Pathol. 2000 Sep;31(9):1011-7.

PMID:
11014564
6.

Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.

Bahrami S, Cheng L, Wang M, Jones TD, Malone JC, Billings SD.

Mod Pathol. 2007 Aug;20(8):821-7. Epub 2007 Jun 15.

7.

Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.

Aubele MM, Cummings MC, Mattis AE, Zitzelsberger HF, Walch AK, Kremer M, Höfler H, Werner M.

Diagn Mol Pathol. 2000 Mar;9(1):14-9.

PMID:
10718208
8.

Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H.

Cancer Res. 1995 Aug 1;55(15):3399-405.

9.

Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization.

Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, Höfler H, Werner M.

Cancer Genet Cytogenet. 1999 Apr 15;110(2):94-102.

PMID:
10214356
10.

Molecular alterations in columnar cell lesions of the breast.

Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S.

Mod Pathol. 2006 Mar;19(3):344-9.

11.

Primary combined malignant melanoma and ductal carcinoma of the breast. A report of two cases.

Padmore RF, Lara JF, Ackerman DJ, Gales T, Sigurdson ER, Ehya H, Cooper HS, Patchefsky AS.

Cancer. 1996 Dec 15;78(12):2515-25.

12.

Metachronous bilateral mammary metaplastic and infiltrating duct carcinomas: a molecular study for clonality.

Kung FY, Tse GM, Lo KW, Law BK, Chang AR, Chen MH.

Hum Pathol. 2002 Jun;33(6):677-9.

PMID:
12152169
13.

Mucinous cancers have fewer genomic alterations than more common classes of breast cancer.

Fujii H, Anbazhagan R, Bornman DM, Garrett ES, Perlman E, Gabrielson E.

Breast Cancer Res Treat. 2002 Dec;76(3):255-60.

PMID:
12462386
14.

Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.

Ariyanayagam-Baksh SM, Baksh FK, Swalsky PA, Finkelstein SD.

Mod Pathol. 2003 Oct;16(10):992-5.

15.

Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.

Sigbjörnsdottir BI, Ragnarsson G, Agnarsson BA, Huiping C, Barkardottir RB, Egilsson V, Ingvarsson S.

J Med Genet. 2000 May;37(5):342-7.

16.

Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma.

Saad RS, Denning KL, Finkelstein SD, Liu Y, Pereira TC, Lin X, Silverman JF.

Mod Pathol. 2008 Oct;21(10):1200-7. doi: 10.1038/modpathol.2008.35. Epub 2008 May 9.

17.

Genotypic analysis of primary and metastatic cutaneous melanoma.

Rao UN, Jones MW, Finkelstein SD.

Cancer Genet Cytogenet. 2003 Jan 1;140(1):37-44.

PMID:
12550756
18.

Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.

Matsumoto T, Fujii H, Arakawa A, Yamasaki S, Sonoue H, Hattori K, Kajiyama Y, Hirose S, Tsurumaru M.

Hum Pathol. 2004 Mar;35(3):322-7.

PMID:
15017588
19.
20.

Fine-needle aspiration of a metaplastic breast carcinoma with extensive melanocytic differentiation: a case report.

Yen H, Florentine B, Kelly LK, Bu X, Crawford J, Martin SE.

Diagn Cytopathol. 2000 Jul;23(1):46-50.

PMID:
10907933

Supplemental Content

Support Center